BridgeBio Inc. is seeking a Skeletal Dysplasia Account Manager for remote USA deployment to drive the launch of Infigratinib, a first-in-class therapy for achondroplasia.
The role focuses on partnering with providers and families, leveraging clinical acumen and urgency to advance access and adoption. The candidate will work with multidisciplinary teams, build strategic territory plans, and lead collaborations with Field Medical Directors, reimbursement, and hub teams to maximize patient impact
#J-18808-LjbffrSkeletal Dysplasia Account Lead - Remote US in oklahoma city at Unknown Company
This position is listed as full time and able to be worked remotely.